World Intellectual Property Organization Publishes Patent Application of Solar3D Solar Cell

Solar3D, Inc., the developer of a breakthrough 3-dimensional solar cell technology to maximize the conversion of sunlight into electricity, today announced the World Intellectual Property Organization, in Geneva, Switzerland, has published the patent application of the Solar3D Solar Cell.

The patent application was filed on Feb.20 under Application No.PCT/US2013/026914 and published on August 29.

"One of the greatest technology opportunities in the solar business is to develop a solar cell that can produce more energy through a longer portion of the day," said Jim Nelson, CEO of Solar3D. "Solar3D Cell is that type of technology. Having our patent application published is an important step in securing broad international intellectual property protection that will allow us to take the product to market with full confidence."

The company's technology team is currently building its 3rd generation prototype, which will be less expensive to manufacture and result in more powerful performance than the previous versions. Its initial 2012 prototype design was calculated to produce just over 25% efficiency, the highest of any silicon solar cell. Even more important was an originally unanticipated feature -- wide-angle light collection -- allowing for the generation of electricity throughout more times of the days and seasons. This feature increases the length of time during which light can be effectively converted to electricity, relative to current technology. Current technology is most effective for a few hours in the middle of the day.

For further information, including images, charts and tables, please visit: http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2013126434

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.